Rkl Wealth Management LLC Amgen Inc Transaction History

Rkl Wealth Management LLC

$1.1 Billion
Q3 2024

A detailed history of Rkl Wealth Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Rkl Wealth Management LLC holds 1,353 shares of AMGN stock, worth $372,643. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,353

Previous 873 54.98%

Holding current value

$372,643

Previous $272,000 59.93%

% of portfolio

0.04%

Previous 0.03%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$309.38 - $337.38 $148,502 - $161,942	480 Added 54.98%	1,353 $435,000
Q2 2024 Jul 17, 2024	SELL	$262.75 - $319.31 $5,780 - $7,024	-22 Reduced 2.46%	873 $272,000
Q1 2024 May 08, 2024	SELL	$268.87 - $324.56 $2,688 - $3,245	-10 Reduced 1.1%	895 $254,000
Q4 2023 Jan 24, 2024	BUY	$255.7 - $288.46 $3,579 - $4,038	14 Added 1.57%	905 $260,000
Q3 2023 Nov 03, 2023	BUY	$218.65 - $271.46 $194,817 - $241,870	891 New	891 $239,000
Q3 2019 Oct 31, 2019	SELL	$174.11 - $208.62 $191,869 - $229,899	-1,102 Closed	0 $0
Q2 2019 Aug 02, 2019	BUY	$166.7 - $195.41 $183,703 - $215,341	1,102 New	1,102 $204,000
Q1 2019 Apr 26, 2019	SELL	$180.87 - $203.88 $196,605 - $221,617	-1,087 Closed	0 $0
Q4 2018 Feb 08, 2019	BUY	$178.4 - $208.25 $7,314 - $8,538	41 Added 3.92%	1,087 $213,000
Q3 2018 Nov 07, 2018	SELL	$185.29 - $208.89 $13,155 - $14,831	-71 Reduced 6.36%	1,046 $217,000
Q2 2018 Aug 03, 2018	BUY	$166.05 - $186.51 $185,477 - $208,331	1,117 New	1,117 $206,000
Q1 2018 Apr 26, 2018	SELL	$169.43 - $198.0 $195,352 - $228,294	-1,153 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$168.79 - $188.59 $114,945 - $128,429	-681 Reduced 37.13%	1,153 $200,000
Q3 2017 Nov 07, 2017	SELL	$167.29 - $191.0 $10,371 - $11,842	-62 Reduced 3.27%	1,834 $341,000
Q2 2017 Aug 14, 2017	BUY	N/A	1,896	1,896 $326,000

Others Institutions Holding AMGN

# of Institutions

3,080

Shares Held

404M

Call Options Held

7.56M

Put Options Held

7.16M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $147B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rkl Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rkl Wealth Management LLC with notifications on news.

Account

Rkl Wealth Management LLC Amgen Inc Transaction History